Northern Trust Corp Eiger Bio Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.93 $5,601 - $18,604	-20,005 Reduced 15.12%	112,323 $33,000
Q2 2023 Aug 11, 2023	SELL	$0.55 - $1.26 $147,976 - $339,001	-269,049 Reduced 67.03%	132,328 $92,000
Q1 2023 May 15, 2023	SELL	$0.89 - $2.52 $6,555 - $18,562	-7,366 Reduced 1.8%	401,377 $361,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $7.48 $6,715 - $49,248	6,584 Added 1.64%	408,743 $482,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $54,837 - $87,703	9,079 Added 2.31%	402,159 $3.03 Million
Q2 2022 Aug 12, 2022	BUY	$4.99 - $8.96 $348,336 - $625,470	69,807 Added 21.59%	393,080 $2.48 Million
Q1 2022 May 13, 2022	SELL	$3.84 - $9.74 $45,838 - $116,266	-11,937 Reduced 3.56%	323,273 $2.68 Million
Q4 2021 Feb 08, 2022	SELL	$5.12 - $8.19 $35,025 - $56,027	-6,841 Reduced 2.0%	335,210 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$6.68 - $9.1 $87,521 - $119,228	-13,102 Reduced 3.69%	342,051 $2.29 Million
Q2 2021 Aug 13, 2021	SELL	$7.82 - $9.23 $143,958 - $169,915	-18,409 Reduced 4.93%	355,153 $3.03 Million
Q1 2021 May 12, 2021	SELL	$8.44 - $12.66 $488,431 - $732,646	-57,871 Reduced 13.41%	373,562 $3.31 Million
Q4 2020 Feb 11, 2021	BUY	$7.98 - $12.29 $140,894 - $216,992	17,656 Added 4.27%	431,433 $5.3 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $208,106 - $324,708	26,144 Added 6.74%	413,777 $3.37 Million
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $354,742 - $878,315	65,693 Added 20.41%	387,633 $3.72 Million
Q1 2020 May 14, 2020	BUY	$4.91 - $14.7 $90,859 - $272,023	18,505 Added 6.1%	321,940 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $48,781 - $78,190	4,993 Added 1.67%	303,435 $4.52 Million
Q3 2019 Nov 13, 2019	BUY	$9.59 - $12.0 $2.01 Million - $2.51 Million	209,581 Added 235.85%	298,442 $3.06 Million
Q2 2019 Aug 13, 2019	BUY	$9.54 - $14.96 $310,069 - $486,229	32,502 Added 57.67%	88,861 $942,000
Q1 2019 May 13, 2019	SELL	$10.31 - $14.38 $45,271 - $63,142	-4,391 Reduced 7.23%	56,359 $788,000
Q4 2018 Feb 12, 2019	BUY	$8.63 - $12.4 $115,685 - $166,222	13,405 Added 28.31%	60,750 $617,000
Q3 2018 Nov 14, 2018	BUY	$9.6 - $12.9 $65,212 - $87,629	6,793 Added 16.75%	47,345 $568,000
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $92,760 - $187,756	11,176 Added 38.04%	40,552 $495,000
Q1 2018 May 09, 2018	BUY	$8.1 - $16.0 $149,712 - $295,728	18,483 Added 169.68%	29,376 $289,000
Q4 2017 Feb 14, 2018	BUY	$10.5 - $14.15 $114,376 - $154,135	10,893	10,893 $152,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account